期刊
MOLECULAR PHARMACEUTICS
卷 9, 期 10, 页码 2956-2959出版社
AMER CHEMICAL SOC
DOI: 10.1021/mp300147v
关键词
water-soluble manganese porphyrin; superoxide dismutase mimic; manganese superoxide dismutase deficient mice; dilated cardiomyopathy; antioxidative therapy
资金
- Japan Society for the Promotion of Science [22300166]
- Grants-in-Aid for Scientific Research [22300166, 24650281] Funding Source: KAKEN
Mice lacking manganese-superoxide dismutase (Mn-SOD) activity exhibit typical pathology of dilated cardiomyopathy (DCM). In the present study, the structure activity relationship between the water-soluble manganese (Mn) porphyrin with SOD activity and the in vivo pharmaceutical effect on DCM is reported. The Mn-SOD-deficient mice were treated with Mn-porphyrins for 3 weeks. The treatment of a Mn-porphyrin, MnM2Py(2)P, suppressed the progression of cardiac dilation. These results suggest that the Mn-porphyrin MnM2Py2P treatment is proposed as a potential therapy for DCM.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据